Astrid Morer Liñan

Dr. Astrid Morer Liñan

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Cell
Verified
Journal Article
Closed access
PLPhil H. Lee
Phil H. Lee
VAVerneri Anttila
Verneri Anttila
HWHyejung Won
Hyejung Won
YFYen-Chen A. Feng
Yen-Chen A. Feng
JRJacob Rosenthal
Jacob Rosenthal
JSJordan Smoller
Jordan Smoller

1 May 2018 in American Journal of Psychiatry
Verified
Journal Article
Closed access
PBPremika S.W. Boedhoe
Premika S.W. Boedhoe
LSLianne Schmaal
Lianne Schmaal
YAYoshinari Abe
Yoshinari Abe
PAPino Alonso
Pino Alonso
SAStephanie H. Ameis
Stephanie H. Ameis
YWYsbrand Van Der Werf
Ysbrand Van Der Werf

1 May 2017 in Neuron
Verified
Journal Article
Closed access
AWA. Jeremy Willsey
A. Jeremy Willsey
TFThomas V. Fernandez
Thomas V. Fernandez
DYDongmei Yu
Dongmei Yu
RKRobert A. King
Robert A. King
ADAndrea Dietrich
Andrea Dietrich
JSJae-Hoon Sul
Jae-Hoon Sul

1 September 2018 in Cell Reports
Verified
Journal Article
Open access
SWSheng Wang
Sheng Wang
JMJeffrey D. Mandell
Jeffrey D. Mandell
YKYogesh Kumar
Yogesh Kumar
NSNawei Sun
Nawei Sun
MMMontana T. Morris
Montana T. Morris
AWA. Jeremy Willsey
A. Jeremy Willsey
We previously established the contribution of de novo damaging sequence variants to Tourette disorder (TD) through whole-exome sequencing of 511 trios. Here, we sequence an additional 291 TD trios and analyze the combined set of 802 trios. We observe an overrepresentation of de novo damaging variants in simplex, but not multiplex, families; we identify a high-confidence TD risk gene, CELSR3 (cadherin EGF LAG seven-pass G-type receptor 3); we find that the genes mutated in TD patients are enriched for those related to cell polarity, suggesting a common pathway underlying pathobiology; and we confirm a statistically significant excess of de novo copy number variants in TD. Finally, we identify significant overlap of de novo sequence variants between TD and obsessive-compulsive disorder and de novo copy number variants between TD and autism spectrum disorder, consistent with shared genetic risk.

1 June 2020 in Biological Psychiatry
Verified
Journal Article
Closed access
XKXiang-Zhen Kong
Xiang-Zhen Kong
PBPremika S.W. Boedhoe
Premika S.W. Boedhoe
YAYoshinari Abe
Yoshinari Abe
PAPino Alonso
Pino Alonso
SAStephanie H. Ameis
Stephanie H. Ameis
CZCong Zhou
Cong Zhou

2 May 2023 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
WBWillem B. Bruin
Willem B. Bruin
YAYoshinari Abe
Yoshinari Abe
PAPino Alonso
Pino Alonso
AAAlan Anticevic
Alan Anticevic
LBLea L. Backhausen
Lea L. Backhausen
DSDan J. Stein
Dan J. Stein
Current knowledge about functional connectivity in obsessive-compulsive disorder (OCD) is based on small-scale studies, limiting the generalizability of results. Moreover, the majority of studies have focused only on predefined regions or functional networks rather than connectivity throughout the entire brain. Here, we investigated differences in resting-state functional connectivity between OCD patients and healthy controls (HC) using mega-analysis of data from 1024 OCD patients and 1028 HC from 28 independent samples of the ENIGMA-OCD consortium. We assessed group differences in whole-brain functional connectivity at both the regional and network level, and investigated whether functional connectivity could serve as biomarker to identify patient status at the individual level using machine learning analysis. The mega-analyses revealed widespread abnormalities in functional connectivity in OCD, with global hypo-connectivity (Cohen’s d: -0.27 to -0.13) and few hyper-connections, mainly with the thalamus (Cohen’s d: 0.19 to 0.22). Most hypo-connections were located within the sensorimotor network and no fronto-striatal abnormalities were found. Overall, classification performances were poor, with area-under-the-receiver-operating-characteristic curve (AUC) scores ranging between 0.567 and 0.673, with better classification for medicated (AUC = 0.702) than unmedicated (AUC = 0.608) patients versus healthy controls. These findings provide partial support for existing pathophysiological models of OCD and highlight the important role of the sensorimotor network in OCD. However, resting-state connectivity does not so far provide an accurate biomarker for identifying patients at the individual level.